UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-42004
NEWGENIVF GROUP LIMITED
(Exact name of registrant as specified in its
charter)
36/39-36/40, 13th Floor, PS Tower
Sukhumvit 21 Road (Asoke)
Khlong Toei Nuea Sub-district
Watthana District, Bangkok 10110
Thailand
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On August 11, 2026, NewGenIvf Group Limited (the “Company”) entered into an Amendment and Exchange Agreement (the “Exchange
Agreement”) with a certain institutional investor (the “Holder”), pursuant to which on August 14, 2026, the Company
issued to the Holder a new senior convertible note in the aggregate principal amount of $7,105,468.75 (the “New Note”) in
exchange for the Holder’s existing convertible notes and related warrants previously issued by the Company to the Holder. In connection
with the Exchange Agreement, on August 14, 2026, the Holder also entered into a Leak-Out Agreement with the Company (the “Leak-Out
Agreement”) restricting the Holder’s sales of the Company’s Class A ordinary shares issuable upon conversion of the
New Note.
On August 17, 2026, the Company issued a press release announcing its
entry into the Exchange Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The foregoing descriptions of the Exchange Agreement, the New Note
and the Leak-Out Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements,
copies of which are filed herewith as Exhibits 10.1, 10.2 and 10.3, respectively, and are incorporated herein by reference.
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 10.1 |
|
Amendment and Exchange Agreement, dated August 11, 2026, by and between NewGenIvf Group Limited and the Holder |
| 10.2 |
|
Form of Senior Convertible Note issued by NewGenIvf Group Limited to the Holder |
| 10.3 |
|
Form of Leak-Out Agreement, dated August 14, 2026, by and between NewGenIvf Group Limited and the Holder |
| 99.1 |
|
Press
Release |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: August 17, 2026
| |
NEWGENIVF GROUP LIMITED |
| |
|
|
| |
By: |
/s/ Wing Fung Alfred Siu |
| |
Name: |
Wing Fung Alfred Siu |
| |
Title: |
Chairman of the Board and Director |
Exhibit 99.1
NewGenIVF Completes
Exchange of Convertible Notes with Institutional Investor
Restructuring eliminates prior mandatory proceeds
sweep and improves capital structure flexibility
BANGKOK, August 17, 2026 – NewGenIVF Group Limited (Nasdaq:
NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has
completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible
notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026.
The restructuring eliminates the prior mandatory requirement that a significant
percentage of proceeds from new capital raises be applied to prepay the notes under the Repurchase and Forbearance Agreement dated June
16, 2026, which was disclosed in the Company’s Form 6-K filing on June 16, 2026. The new note also incorporates a leak-out framework
and other modified terms intended to provide greater flexibility for the Company. The full agreement will be filed as an exhibit to the
Company's Report on Form 6-K, which will be furnished to the U.S. Securities and Exchange Commission simultaneously with this press release.
“This exchange represents an important step in improving the terms
of our capital structure,” said Alfred Siu, Founder, Chairman and CEO of NewGen. “By removing the previous mandatory proceeds
sweep and establishing more constructive terms, we enhance our ability to manage future financing activity in a manner that better supports
the Company’s strategic objectives and long-term growth.”
The Company continues to evaluate additional opportunities to further
optimize its capital structure in a manner consistent with shareholder interests.
About NewGen
NewGenIVF Group Limited is a technology-forward, diversified growth company
pursuing opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates
through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on
digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF’s
legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information
contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning
of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in
this press release include, but are not limited to, statements regarding: the anticipated benefits of the exchange of the Investor's
existing convertible notes for a new senior convertible note on amended terms, including the elimination of the prior mandatory proceeds
sweep and the leak-out framework and other modified terms intended to provide greater flexibility for the Company; the Company's ability
to manage future financing activity in a manner that supports its strategic objectives and long-term growth; and the Company's plans
to continue evaluating additional opportunities to optimize its capital structure.
These forward-looking statements are based on the Company's current expectations,
estimates, projections and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties
and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These
risks and uncertainties include, among others: risk relating to the Company's convertible note financing arrangements, including compliance
with associated covenants and the risk of default; share dilution and capital markets issuance risk; and liquidity and capital requirements
risk. Additional risks are described in the Company's Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange
Commission.
All information provided in this press release is as of the date of this
press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable
securities laws.
Contacts
ICR, LLC
Robin Yang
Phone: +1 (212) 537-3847
Email: Newgenivf.IR@icrinc.com